Compare Stocks

Canadian Tire Corporation, Limited provides a range of retail goods and services in Canada. It operates in three segments: Retail, CT REIT, and Financial Services. The Retail segment retails automotive maintenance products and accessories, parts, and tires, as well as automotive services and roadside assistance; electrical, hardware, home environment, paint, plumbing, and tool products; cleaning, food & drink, home décor, home essentials, home organization, kitchen, and pet care products; camping, exercise, hockey, hunting, fishing, seasonal recreation, and team sports and golf products; and backyard living, backyard fun, cycling, gardening, outdoor tools, seasonal, and toy products. This segment offers its products under the Canadian Tire, Canadian Tire Gas, Pro Hockey Life, Mark's, PartSource, Helly Hansen, Party City, and SportChek brand names. This segment also participates in loyalty programs, as well as sells its products online. The CT REIT segment operates as a closed-end real estate investment trust that holds a portfolio of properties comprising Canadian Tire stores, Canadian Tire anchored retail developments, industrial properties, mixed-use commercial property, and development properties. The Financial Services segment provides consumer credit cards, in-store financing, insurance products, and retail and broker deposits; and savings accounts and guaranteed investment certificates. Canadian Tire Corporation, Limited was founded in 1922 and is headquartered in Toronto, Canada.

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

Leon's Furniture Limited, together with its subsidiaries, operates as a retailer of home furnishings, mattresses, appliances, and electronics in Canada. It operates in two segments, Leon's and The Brick. The company provides repair services for household furniture, electronics, and appliances; home office products; warranties; and credit insurance products, including life, dismemberment, disability, critical illness, and involuntary unemployment. It also operates as a commercial retailer of appliances to builders, developers, renovators, property management companies, hotels, extended care industries, landlords, government bodies, and insurance companies; and engages in the franchise operations. The company sells its products through a network of retail stores under the Leon's, The Brick, The Brick Outlet, and The Brick Mattress Store banners; and the Brick's Midnorthern Appliance and Appliance Canada banners, as well as through its websites, including leons.ca, thebrick.com, furniture.ca, midnorthern.com, transglobalservices.com, and applicancecanada.com. The company was formerly known as Ablan Leon Distributors Limited and changed its name to Leon's Furniture Limited in June 1969. Leon's Furniture Limited was founded in 1909 and is headquartered in Toronto, Canada.

The Cyber Hornet S&P 500 and Bitcoin 75/25 Strategy ETF (ZZZ) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund tracks an index that provides 75/25 exposure to US large-cap stocks and front-month CME Bitcoin futures, respectively. The fund does not directly invest in Bitcoin, nor does it maintain direct exposure to its spot price. ZZZ was launched on Dec 28, 2023 and is issued by Onefund.